Treatment Options for Relapsed Small-Cell Lung Cancer: What Progress Have We Made?

被引：15
|
作者：
Qin, Angel [1 ]
Kalemkerian, Gregory P. [1 ]
机构：
[1] Univ Michigan, Ann Arbor, MI 48109 USA
来源：
JOURNAL OF ONCOLOGY PRACTICE | 2018年 / 14卷 / 06期
关键词：
PHASE-III TRIAL; 2ND-LINE TREATMENT; OPEN-LABEL; TOPOTECAN; IRINOTECAN; CISPLATIN; ETOPOSIDE;
D O I：
10.1200/JOP.18.00278
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：369 / +
页数：3
相关论文
共 50 条
  • [31] Erratum: Small-cell lung cancer: what we know, what we need to know and the path forward
    Adi F. Gazdar
    Paul A. Bunn
    John D. Minna
    [J]. Nature Reviews Cancer, 2017, 17 : 765 - 765
  • [32] Chemotherapy as adjuvant therapy for completely resected non-small-cell lung cancer: Have we made progress?
    Feld, R
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1996, 14 (04) : 1045 - 1047
  • [33] Combination Olaparib and Temozolomide in Relapsed Small-Cell Lung Cancer
    Farago, Anna F.
    Yeap, Beow Y.
    Stanzione, Marcello
    Hung, Yin P.
    Heist, Rebecca S.
    Marcoux, J. Paul
    Zhong, Jun
    Rangachari, Deepa
    Barbie, David A.
    Phat, Sarah
    Myers, David T.
    Morris, Robert
    Kem, Marina
    Dubash, Taronish D.
    Kennedy, Elizabeth A.
    Digumarthy, Subba R.
    Sequist, Lecia V.
    Hata, Aaron N.
    Maheswaran, Shyamala
    Haber, Daniel A.
    Lawrence, Michael S.
    Shaw, Alice T.
    Mino-Kenudson, Mari
    Dyson, Nicholas J.
    Drapkin, Benjamin J.
    [J]. CANCER DISCOVERY, 2019, 9 (10) : 1372 - 1387
  • [34] SALVAGE NOGITECAN CHEMOTHERAPY FOR RELAPSED SMALL-CELL LUNG CANCER
    Hiyoshi, Y.
    Fukui, T.
    Nagashima, Y.
    Takakura, A.
    Katono, K.
    Yokoba, M.
    Sasaki, J.
    Masuda, N.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 : 79 - 79
  • [35] LURBINECTEDIN IS SAFE AND ACTIVE IN RELAPSED SMALL-CELL LUNG CANCER
    不详
    [J]. CANCER DISCOVERY, 2020, 10 (06) : 757 - 757
  • [36] Is relapsed small-cell lung cancer (SCLC) under treated?
    Nicum, S.
    Ashley, S.
    O'Brien, M.
    [J]. EJC SUPPLEMENTS, 2007, 5 (04): : 377 - 377
  • [37] Cisplatin, etoposide, and irinotecan for relapsed small-cell lung cancer
    Qin, Angel
    Kalemkerian, Gregory P.
    [J]. TRANSLATIONAL CANCER RESEARCH, 2016, 5 : S1142 - S1144
  • [38] Treatment strategy for patients with relapsed small-cell lung cancer: past, present and future
    Wakuda, Kazushige
    [J]. TRANSLATIONAL LUNG CANCER RESEARCH, 2020, 9 (02) : 172 - 179
  • [39] Dose-intensive weekly chemotherapy for treatment of relapsed small-cell lung cancer
    Kubota, K
    Nishiwaki, Y
    Kakinuma, R
    Hojo, F
    Matsumoto, T
    Ohmatsu, H
    Sekine, I
    Yokozaki, M
    Goto, K
    Ebi, N
    Kodama, T
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 1997, 15 (01) : 292 - 296
  • [40] Albumin-bound paclitaxel for the treatment of refractory or relapsed small-cell lung cancer
    Yoshida, Hironori
    Kim, Young Hak
    Ozasa, Hiroaki
    Nagai, Hiroki
    Sakamori, Yuichi
    Nakaoku, Takashi
    Yagi, Yoshitaka
    Tsuji, Takahiro
    Nomizo, Takashi
    Mishima, Michiaki
    [J]. MOLECULAR AND CLINICAL ONCOLOGY, 2016, 5 (01) : 213 - 215
12345